InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the complete record of transactions filed by Moore Paul Andrew. Director active across 1 company, notably Zymeworks Inc.. Cumulatively, 4 disclosures have been published. Activity tracked since 5 January 2024. The latest transaction was filed on 12 January 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Paul Andrew Moore has 4 filings in total. The 4 sampled filings, all at Zymeworks Inc., cover the period from 2024-01-08 to 2026-01-12, with buy and sell amounts of EUR 0, and the most frequent transaction nature is Levée d'options. Since his primary role is not provided, he is simply a declarant linked to Zymeworks Inc., where his listed function is Chief Scientific Officer.